GAINESVILLE, Fla. – August 9, 2010 – Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced its schedule of participation at upcoming investor conferences:

Tuesday, August 10, 2010 – 8:30 am Eastern time
Canaccord Genuity 30th Annual Growth Conference 2010, Boston, MA

Wednesday, September 15, 2010 - 2:15 pm Eastern time
Robert W. Baird & Co. 2010 Health Care Conference, New York City

Thursday, September 16, 2010 – 3:50 pm Eastern time
Stifel Nicolaus Healthcare Conference 2010, Boston, MA

An investment profile and complete investor utility on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

About Exactech
Based in Gainesville, Fla., Exactech is celebrating its 25th anniversary developing and marketing orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

Investor contacts
Jody Phillips
Chief Financial Officer
352-377-1140

Julie Marshall or Frank Hawkins
Hawk Associates
305-451-1888
E-mail: exactech@hawkassociates.com

PDF